Provided by Tiger Trade Technology Pte. Ltd.

Spruce Biosciences, Inc.

51.58
-0.4050-0.78%
Pre-market: 55.003.42+6.63%08:42 EDT
Volume:62.31K
Turnover:3.18M
Market Cap:148.24M
PE:-1.34
High:53.00
Open:52.48
Low:49.03
Close:51.99
52wk High:240.00
52wk Low:7.26
Shares:2.87M
Float Shares:2.29M
Volume Ratio:1.21
T/O Rate:2.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-38.4300
EPS(LYR):-50.8298
ROE:-105.98%
ROA:-40.03%
PB:1.77
PE(LYR):-1.01

Loading ...

Spruce Biosciences, Inc : H.c. Wainwright Cuts Target Price to $150 From $200

THOMSON REUTERS
·
Jun 01

Spruce Biosciences Announces Data Presentation At The 18Th International MPS Symposium

Reuters
·
May 29

Spruce Biosciences to present long-term tralesinidase alfa data in Sanfilippo syndrome Type B at International MPS Symposium

Reuters
·
May 29

Spruce Biosciences Announces Data Presentation at the 18TH International Mps Symposium

THOMSON REUTERS
·
May 29

Spruce Biosciences to present at Jefferies Global Healthcare Conference

Reuters
·
May 28

Analysts’ Top Healthcare Picks: Spruce Biosciences (SPRB), CG Oncology, Inc. (CGON)

TIPRANKS
·
May 27

Spruce Biosciences Stockholders Approve Directors and Annual Say-on-Pay

TIPRANKS
·
May 27

Spruce Biosciences shareholders elect Class III directors at annual meeting

Reuters
·
May 27

Spruce Biosciences, Inc : Leerink Partners Cuts Target Price to $120 From $140

THOMSON REUTERS
·
May 14

Spruce Biosciences Is Maintained at Market Outperform by Citizens

Dow Jones
·
May 14

Spruce Biosciences price target lowered to $150 from $170 at Citizens

TIPRANKS
·
May 14

Spruce Biosciences reports Q1 EPS ($8.94), consensus ($6.11)

TIPRANKS
·
May 14

Spruce Biosciences, Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Spruce Biosciences Q1 FY26 net loss narrows to $12.27 million; R&D expenses fall to $7.58 million

Reuters
·
May 13

Spruce Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates

THOMSON REUTERS
·
May 13

Spruce Biosciences, Inc expected to post a loss of $8.82 a share - Earnings Preview

Reuters
·
May 08

BRIEF-Spruce Biosciences Further Strengthens Its Commercial Leadership Team With The Appointments Of Brian Walls As Vice President, Market Access And Darren Johnson As Vice President, Commercial Operations

Reuters
·
May 04

Spruce Biosciences Further Strengthens Its Commercial Leadership Team With the Appointments of Brian Walls as Vice President, Market Access and Darren Johnson as Vice President, Commercial Operations

THOMSON REUTERS
·
May 04

Spruce Biosciences, Inc expected to post a loss of $8.82 a share - Earnings Preview

Reuters
·
May 01

Spruce Biosciences Initiated at Buy by Craig-Hallum

Dow Jones
·
Apr 28